Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02854969
Other study ID # AnapphylaxisQoL
Secondary ID
Status Completed
Phase N/A
First received July 22, 2016
Last updated July 25, 2017
Start date May 2016
Est. completion date July 18, 2017

Study information

Verified date August 2016
Source Adan Medical Innovation, SL
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Through several questionaries the investigators will measure the satisfaction of patients diagnosed with anaphylaxis in the use of a medical device for the adrenaline autoinjector, a smart case for an epinephrine autoinjector connected via Bluetooth to a mobile application.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date July 18, 2017
Est. primary completion date July 18, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients 18 years old or above

- Patients diagnosed with Anaphylaxis and an epinephrine auto-injector prescribed

- Patients with a smartphone

- Patients who signed the informed consent

Exclusion Criteria:

- Patients who have not signed the informed consent

- Patients with some limitations for understanding or following correctly the trial procedures

- Pregnant or nursing women

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Device: Anapphylaxis


Locations

Country Name City State
Spain Hospital Vall d'Hebron Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Adan Medical Innovation, SL

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient satisfaction through a questionnaire in the use of the medical device 3 months
Secondary Medical device safety Adverse events related to the medical device 3 months
Secondary Patient Adherence to the medical device through a questionnaire 3 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04475003 - Health Literacy Among Caregivers of Children With IgE-mediated Allergy With Risk of Anaphylaxis
Recruiting NCT04615065 - Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Recruiting NCT06065137 - Standardised Drug Provocation Testing in Perioperative Hypersensitivity N/A
Completed NCT00047918 - Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing N/A
Active, not recruiting NCT03953482 - Evaluation of Medical Care and Patient's Knowledge About the Behavior to Take on Secondary Prevention of Anaphylaxis
Recruiting NCT05112367 - Epidemiology and Management of Pediatric Anaphylaxis and Allergy in the Pediatric Emergency Department of Montpellier
Completed NCT03366298 - Pharmacokinetics of Intramuscular Adrenaline in Food--Allergic Teenagers Phase 4
Completed NCT02958605 - Smartphone Apps for Pediatric Resuscitation N/A
Completed NCT04696822 - Bioavailability of Nasal Epinephrine Phase 1
Completed NCT03942692 - What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction
Completed NCT03282929 - Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD) Phase 1
Recruiting NCT01326741 - Clonal Mast Cell Disorders in Exercise-Induced Anaphylaxis N/A
Recruiting NCT06445374 - Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges Phase 1
Completed NCT01217138 - Make up for the Epinephrine Autoinjector Phase 4
Completed NCT02424136 - PEAnut Anaphylaxis Predictors N/A
Completed NCT01432522 - A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine N/A
Completed NCT02028065 - A Study to Evaluate the Incidence of Hypersensitivity After Administration of Sugammadex in Healthy Participants (MK-8616-101) Phase 1
Active, not recruiting NCT01247415 - Clinical Investigation on Allergic-like Reactions and Oculo-respiratory Syndrome After the H1N1 Pandemic Vaccine N/A
Completed NCT00868842 - Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis N/A
Completed NCT04290507 - Epidemiology and Outcome of Anaphylactic Shocks Admitted to Intensive Care Unit